Table 5 |
||||||
|
Aspergillus disease in patients with other chronic inflammatory joint diseases: literature review |
||||||
|
Type of Aspergillus disease |
Site |
Joint disease |
Other treatmenta |
TNFα antagonist |
Outcome |
Reference |
|
|
||||||
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
? |
-- |
? |
[43] |
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
Radiation therapy |
-- |
Recovery |
[44] |
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
? |
-- |
Recovery |
[45] |
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
? |
-- |
? |
[46] |
|
Aspergilloma (× 2) |
Lung |
Ankylosing spondylitis |
Radiation therapy |
-- |
Recovery, recurrence |
[47] |
|
Aspergilloma + invasive aspergillosis |
Lung |
Ankylosing spondylitis |
? |
-- |
Improvement |
[17] |
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
? |
? |
Recovery |
[48] |
|
Aspergilloma |
Lung |
Ankylosing spondylitis |
? |
-- |
Recovery |
[49] |
|
Aspergillosis |
Frontal sinus, meningitis, encephalitis |
Chronic polyarthritis |
GC |
-- |
Recovery |
[50] |
|
Invasive aspergillosis |
Lung |
Crohn's disease |
-- |
Infliximab |
Death |
[20] |
|
Aspergillosis |
Intra-cranial |
Ankylosing spondylitis |
GC |
Etanercept |
Recovery |
[19] |
|
|
||||||
|
aIncluding glucocorticoid therapy (GC) and disease-modifying antirheumatic drugs. |
||||||
|
Leboime et al. Arthritis Research & Therapy 2009 11:R164 doi:10.1186/ar2849 |
||||||
